ePrints

Should neurologists wait and see or see and treat RRMS?

Lookup NU author(s): Emeritus Professor David Bates, Professor John IsaacsORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Early and aggressive treatment of rheumatoid arthritis (RA) is now regarded as best practice to limit irreversible joint damage. However, in the case of relapsing remitting multiple sclerosis (RRMS), current guidelines recommend that disease modifying therapy should only be initiated in patients with evidence of actively progressing disease. Here, the authors present the key findings of the Programme Identifying and Observing Novel Therapy Adoption in Chronic Diseases (PIONEER) study to examine the reasons for these different management approaches.

Publication metadata

Author(s): Bates D, Isaacs J

Publication type: Article

Publication status: Published

Journal: Progress in Neurology and Psychiatry

Year: 2009

Volume: 13

Issue: 5

Pages: 9-15

ISSN (print): 1367-7543

ISSN (electronic): 1931-227X

Publisher: John Wiley & Sons, Inc.

URL: http://dx.doi.org/10.1002/pnp.135

DOI: 10.1002/pnp.135

Altmetrics

Share